PHARMALORRAINE
ActivePHARMALORRAINE has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.62M and a net result of €115k. Equity is growing by ~6.2% per year across the filed fiscal years. Its solvency ranks better than 84% of 4123 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
86
/ 100
Excellent▼ -3 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability35▼-11
Solvency98▲+10
Growth60=
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €140k at 30 days acceptable
Liquidity ample (current ratio 1.91 against 1.44 in 2024), and 28.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
71.9%
Return on assets
5.1%
Age of the figures
8 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
20 d late
2024
72 d early
2023
19 d late
2022
6 d early
2021
18 d late
2020
29 d early
2019
28 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€2.15M▼ 2.3%
2018 · €2.20M
2018: €2.20M
2018 → 2019
EBIT margin
0.9%▼ 6.1pp
2018 · 7.0%
2018: 7.0%
2018 → 2019
Net result
€115k▼ 16.4%
2024 · €138k
2018: €90k
2019: €35k
2020: €92k
2021: €174k
2022: €149k
2023: €72k
2024: €138k
2018 → 2025
Working capital
€336k▲ 61.7%
2024 · €208k
2018: €15k
2019: €-15k
2020: €48k
2021: €16k
2022: €85k
2023: €97k
2024: €208k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.25M-€1.30M▲ 3.9%€1.37M▲ 5.6%€1.51M▲ 10.0%€1.62M▲ 7.6%
Operating result€239k-€213k▼ 10.8%€123k▼ 42.4%€224k▲ 82.1%€180k▼ 19.5%
Net result€174k-€149k▼ 14.1%€72k▼ 51.5%€138k▲ 90.4%€115k▼ 16.4%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 19% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.26M
Fixed assets
€1.55M▼ 3.0%
Current assets
€708k▲ 4.6%
Equity and liabilities €2.26M
Equity
€1.62M▲ 7.6%
Debt
€634k▼ 17.2%
The debt ratio falls from 33.6% to 28.1%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€235k▼
2024 · €285k
Cash flow
€170k▼
2024 · €199k
Solvency
71.9%▲
2024 · 66.4%
Current ratio
1.91▲
2024 · 1.44
Quick ratio
1.44▲
2024 · 1.05
Debt / equity
0.39▼
2024 · 0.51
ROE
7.1%▼
2024 · 9.1%
ROA
5.1%▼
2024 · 6.0%
Interest coverage
9.63▲
2024 · 7.91
Debt
€634k▼
2024 · €766k
Debt ≤ 1 year
€371k▼
2024 · €469k
Debt > 1 year
€228k▼
2024 · €270k
Income taxes
€42k▼
2024 · €51k
Staff costs
€221k▲
2024 · €220k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.28M€2.26M▼
Fixed assets21/28€1.60M€1.55M▼
Tangible fixed assets22/27€526k€478k▼
Land and buildings22€517k€473k▼
Plant, machinery and equipment23€558€61▼
Furniture and vehicles24€8k€5k▼
Financial fixed assets28€1.07M€1.07M=
Current assets29/58€677k€708k▲
Stocks and contracts in progress3€184k€172k▼
Stocks30/36€184k€172k▼
Amounts receivable within one year40/41€339k€418k▲
Trade receivables40€117k€119k▲
Other amounts receivable41€222k€299k▲
Current investments50/53€16k€17k▲
Cash at bank and in hand54/58€118k€85k▼
Deferred charges and accrued income490/1€20k€16k▼
Equity and liabilities
Total equity and liabilities10/49€2.28M€2.26M▼
Equity10/15€1.51M€1.62M▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€686k€686k=
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€680k€680k=
Profit (loss) carried forward14€761k€877k▲
Amounts payable17/49€766k€634k▼
Amounts payable after more than one year17€270k€228k▼
Financial debts170/4€270k€228k▼
Amounts payable within one year42/48€469k€371k▼
Current portion of amounts payable after more than one year42€40k€42k▲
Financial debts43€137k€138k▲
Credit institutions430/8€137k€138k▲
Trade debts44€138k€128k▼
Suppliers440/4€138k€128k▼
Taxes, remuneration and social security45€80k€32k▼
Taxes450/3€47k€8k▼
Remuneration and social security454/9€33k€24k▼
Other amounts payable47/48€74k€32k▼
Accrued charges and deferred income492/3€28k€35k▲
Income statement
Code20242025
Remuneration, social security and pensions62€220k€221k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€61k€55k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€2k
Other operating charges640/8€9k€8k▼
Non-recurring operating charges66A€13k€0▼
Gross operating margin9900€527k€466k▼
Operating profit (loss)9901€224k€180k▼
Financial income75/76B€638€650▲
Recurring financial income75€638€650▲
Financial charges65/66B€36k€24k▼
Recurring financial charges65€36k€24k▼
Profit (loss) for the period before taxes9903€189k€157k▼
Income taxes67/77€51k€42k▼
Profit (loss) for the period9904€138k€115k▼
Profit (loss) for the period to be appropriated9905€138k€115k▼
Appropriation of the result
Profit (loss) to be appropriated9906€761k€877k▲
Profit (loss) brought forward from the previous period14P€624k€761k▲
Social balance
Average headcount (FTE)90874.03.8▼
The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 20 days late
2025
20-05
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
19-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 19 days late
2023
25-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
18-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 18 days late
2021
31-12
Financial
Highest result since 2018net €174k ▲89%
Operating result €239k, net result €174k, both a record.
02-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 28 days late
2019
31-12
Financial
Weakest financial yearnet €35k ▼61.8%
Net result drops to €35k, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 30 days late
2018
28-09
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 59 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aubange · 1 establishment unit since 1995
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Avenue de la Gare - AUBANGE 36790 Aubange1 establishment unit
Avenue de la Gare - AUBANGE 3, 6790 Aubange
since 19952.072.132.608
Similar companies · same sector, comparable size
Apoteek Jespers - Cuijpers
BE 0440.256.175
Anderlecht · Eq €1.63M
APOTHEEK 'T HOUTEN KRUIS
BE 0476.200.318
Waasmunster · Eq €1.63M
INGE THOELEN
BE 0895.720.863
Landen · Eq €1.63M
APOTHEEK KAREN LIEVENS
BE 0414.457.541
Lokeren · Eq €1.63M
APOTHEEK MICHIELS
BE 0442.751.352
Zoersel · Eq €1.63M
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 2,589 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded20-04-1995
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
68201Renting and operating of own or leased residential real estate, excluding social housing
70201
Sources
Crossroads Bank for EnterprisesNational Bank · 30 filings
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.